Dose monitoring of 5-fluorouracil in patients with colorectal or head and neck cancer--status of the art - PubMed

Review

Dose monitoring of 5-fluorouracil in patients with colorectal or head and neck cancer--status of the art

E Gamelin et al. Crit Rev Oncol Hematol. 1999 Mar.

Similar articles

• [Successes in late solid tumors. New therapy offer].

  Arnheim K. Arnheim K. MMW Fortschr Med. 2004 Nov 18;146(47):71. MMW Fortschr Med. 2004. PMID: 15624667 German. No abstract available.

• [Therapeutic drug monitoring of 5-fluorouracil after its administration in high-dose protocols].

  Boisdron-Celle M, Le Guellec C; Suivi Thérapeutique Pharmacologique de la Société Française de Pharmacologie et de Thérapeutique. Boisdron-Celle M, et al. Therapie. 2010 May-Jun;65(3):171-6. doi: 10.2515/therapie/2010023. Epub 2010 Aug 11. Therapie. 2010. PMID: 20699067 Review. French.

• Special report: laboratory testing to allow area under the curve (AUC)-targeted 5-fluorouracil dosing for patients administered chemotherapy for cancer.

  [No authors listed] [No authors listed] Technol Eval Cent Assess Program Exec Summ. 2010 Jun;24(10):1-3. Technol Eval Cent Assess Program Exec Summ. 2010. PMID: 20575187 No abstract available.

• 5-Fluorouracil in colorectal cancer, a never ending story.

  Herrmann R. Herrmann R. Ann Oncol. 1996 Aug;7(6):551-2. doi: 10.1093/oxfordjournals.annonc.a010668. Ann Oncol. 1996. PMID: 8879365 No abstract available.

• The French experience with infusional 5-fluorouracil in advanced colorectal cancer.

  de Gramont A, Louvet C, Krulik M. de Gramont A, et al. J Infus Chemother. 1996 Summer;6(3):133-6. J Infus Chemother. 1996. PMID: 9229324 Review.

Cited by

• Comparison of the therapeutic effects of the dietary and topical forms of Zizyphus jujuba extract on oral mucositis induced by 5-fluorouracil: A golden hamster model.

  Koohi-Hosseinabadi O, Andisheh-Tadbir A, Bahadori P, Sepehrimanesh M, Mardani M, Tanideh N. Koohi-Hosseinabadi O, et al. J Clin Exp Dent. 2015 Apr 1;7(2):e304-9. doi: 10.4317/jced.52198. eCollection 2015 Apr. J Clin Exp Dent. 2015. PMID: 26155351 Free PMC article.

• A well-tolerated 5-FU-based treatment subsequent to severe capecitabine-induced toxicity in a DPD-deficient patient.

  Blasco H, Boisdron-Celle M, Bougnoux P, Calais G, Tournamille JF, Ciccolini J, Autret-Leca E, Le Guellec C. Blasco H, et al. Br J Clin Pharmacol. 2008 Jun;65(6):966-70. doi: 10.1111/j.1365-2125.2008.03106.x. Epub 2008 Feb 20. Br J Clin Pharmacol. 2008. PMID: 18294332 Free PMC article. No abstract available.

• Matrix metalloproteinase-8 mediates the unfavorable systemic impact of local irradiation on pharmacokinetics of anti-cancer drug 5-Fluorouracil.

  Hsieh CH, Liu CY, Hsieh YJ, Tai HC, Wang LY, Tsai TH, Chen YJ. Hsieh CH, et al. PLoS One. 2011;6(6):e21000. doi: 10.1371/journal.pone.0021000. Epub 2011 Jun 9. PLoS One. 2011. PMID: 21695264 Free PMC article.

• Mechanism of 5-fluorouracil induced resistance and role of piperine and curcumin as chemo-sensitizers in colon cancer.

  Bhattacharjya D, Sivalingam N. Bhattacharjya D, et al. Naunyn Schmiedebergs Arch Pharmacol. 2024 Nov;397(11):8445-8475. doi: 10.1007/s00210-024-03189-2. Epub 2024 Jun 15. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 38878089 Review.

• Modeling the 5-fluorouracil area under the curve versus dose relationship to develop a pharmacokinetic dosing algorithm for colorectal cancer patients receiving FOLFOX6.

  Kaldate RR, Haregewoin A, Grier CE, Hamilton SA, McLeod HL. Kaldate RR, et al. Oncologist. 2012;17(3):296-302. doi: 10.1634/theoncologist.2011-0357. Epub 2012 Mar 1. Oncologist. 2012. PMID: 22382460 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information